Latest Regenerative Neurology News

Subscribe

Chinese Study Reports Intranasal Muse Stem Cells Show Potential for Parkinson’s Treatment

Researchers report that intranasal Muse cells improved motor function and reduced neurodegeneration in a Parkinson’s mouse model.

Cyto-Facto to Manufacture Steminent’s Stem Cell Therapy for Spinocerebellar Ataxia, Seeking Conditional Approval in Japan

Stemchymal's CDMO has been selected, while the company seeks conditional approval in both Japan and Taiwan following Phase II results.

Chinese Phase 1 Parkinson’s Stem Cell Trial Reportedly Showing Promise

South China Morning Post says it spoke with the iPSC research team, who relayed that the brain stem cell implant is showing promise in Parkinson's.

BlueRock Therapeutics’ Cell Therapy for Parkinson’s Gains Special Designation in Japan

Japan’s SAKIGAKE designation may help accelerate development and review of the embryonic stem cell-derived therapy.

Hope Biosciences Reports Positive Phase II Results for Parkinson’s Stem Cell Therapy

The Phase II trial showed significant motor function improvements and safety for an allogeneic stem cell therapy in Parkinson’s disease.

UC Irvine Awarded $12 Million for First Human Trial of Stem Cell Therapy in Huntington’s Disease

A pioneering UC Irvine study will assess the safety and potential benefits of embryo-derived neural stem cell therapy for Huntington’s disease.

New Korean Stem Cell Hub Coming to Baltimore, Focused on OA and Alzheimer’s Research

Nature Cell’s new facility will focus on stem cell therapeutics, research, and manufacturing, supported by the Maryland Stem Cell Research Fund.

Aspen Neuroscience Secures $115 Million Funding for Parkinson’s Stem Cell Therapy

The new funding round will help advance their iPSC-derived dopaminergic neuronal precursor cell trials, manufacturing, and continued development of other iPSC therapies.

Interview: siRNA-Loaded Stem Cell Exosomes, Inside NurExone Biologic’s Spinal Cord Injury Candidate

NurExone's SCI candidate showed 100% gait recovery in rat models, and they're gearing up for human trials hopefully in 2026. Enjoy the interview!

TheWell Bioscience Introduces VitroGel® NEURON, a Synthetic Hydrogel Enhancing Neuronal Cell Culture

Designed for 2D and 3D cultures, this platform aims to offer greater consistency and scalability in neuronal research.
Load More
x
Subscribe
Subscribe

Stay updated on Regenerative Medicine

Subscribe